<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Coffee consumption has been associated with lower risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the <z:hpo ids='HP_0011009'>acute</z:hpo> effects of decaffeinated coffee and the major coffee components <z:chebi fb="2" ids="16112">chlorogenic acid</z:chebi> and trigonelline on <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We conducted a randomized crossover trial of the effects of 12 g decaffeinated coffee, 1 g <z:chebi fb="2" ids="16112">chlorogenic acid</z:chebi>, 500 mg trigonelline, and placebo (1 g <z:chebi fb="1" ids="29864">mannitol</z:chebi>) on <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin concentrations during a 2-h oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) in 15 overweight men </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:chebi fb="2" ids="16112">Chlorogenic acid</z:chebi> and trigonelline ingestion significantly reduced <z:chebi fb="105" ids="17234">glucose</z:chebi> (-0.7 mmol/l, P = 0.007, and -0.5 mmol/l, P = 0.024, respectively) and insulin (-73 pmol/l, P = 0.038, and -117 pmol/l, P = 0.007) concentrations 15 min following an OGTT compared with placebo </plain></SENT>
<SENT sid="4" pm="."><plain>None of the treatments affected insulin or <z:chebi fb="105" ids="17234">glucose</z:chebi> area under the curve values during the OGTT compared with placebo </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: <z:chebi fb="2" ids="16112">Chlorogenic acid</z:chebi> and trigonelline reduced early <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin responses during an OGTT </plain></SENT>
</text></document>